Percutaneous approach in the maintenance and salvage of dysfunctional autologous vascular access for dialysis
Related Experiment Video
Updated: May 24, 2026

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
Paola De Rango1, Basso Parente, Enrico Cieri
1Unit of Vascular and Endovascular Surgery, Hospital S. M. Misericordia and University of Perugia, Perugia, Italy. pderango@unipg.it
Insights
Endovascular angioplasty offers a safe and effective method for salvaging failing vascular access, serving as a repeatable, cost-effective bridge solution. While mid-term durability is limited, it can prolong access survival and avoid repeat surgeries.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Nephrology
Background:
- Endovascular procedures are increasingly utilized for failing vascular access, but outcomes remain debated.
- Assessing mid-term patency and complication rates is crucial for treatment planning.
Purpose of the Study:
- To evaluate the mid-term patency and complication rates of endovascular angioplasty for treating stenosis in failing vascular accesses.
- To compare endovascular outcomes with open surgical procedures.
Main Methods:
- A prospective database of vascular accesses from 2006-2010 was analyzed.
- 531 consecutive procedures were reviewed, focusing on 64 endovascular angioplasties for stenosis.
- Patency rates were calculated using the Kaplan-Meier method.
Main Results:
- Endovascular angioplasty achieved a 95.3% immediate technical success rate with a 6.3% complication rate.
- Primary patency rates for angioplasty were 55% at 6 months, 49% at 12 months, and 21% at 24 months.
- Surgical reintervention showed higher initial patency (80% at 6 months) but similar 24-month rates (49%); angioplasty incurred additional costs.
Conclusions:
- Endovascular angioplasty is a safe and effective option for most dysfunctional vascular accesses.
- Despite limited mid-term durability, angioplasty serves as a repeatable, cost-effective bridge to prolong access survival.
- High mid-term failure rates can also occur after surgical reintervention.
Purpose:
Endovascular procedures have been increasingly used for salvage of failing vascular access with conflicting results. The aim of this study was to assess the mid-term patency and complication rates of angioplasty procedures performed in a single center for treatment of stenosis compromising vascular accesses.
Methods:
A prospective database of vascular accesses performed in 2006-2010 was investigated. The endovascular approach was applied following a standardized protocol by a dedicated team. A total of 531 consecutive procedures were reviewed (326 men; mean age 70.94 years). Patency rates were estimated using the Kaplan-Meier method.
Results:
There were 199 procedures for failing access: 135 were surgical and 64 angioplasties performed for anastomosis (n=27), venous (n=45) or arterial (n=7) stenosis. Immediate technical success of endovascular procedures was 95.3%(61/64); complication rate was 6.3% (4/64). Primary patency rates were 55% at six months, 49% at 12 months, and 21% at 24 months. In the concurrent group of 135 open procedures, primary patency rates were 80% at six months and 67% at 12 months (P=.002); nevertheless, at 24 months, patency was as low as 49%. Cost estimates for angioplasty revealed additional fees ranging from 411.34 to 446.34 Euro with respect to open surgical procedures.
Conclusions:
Most dysfunctional vascular accesses can be successfully and safely treated by the endovascular route. In spite of poor mid-term durability, the angioplasty balloon might be considered as a bridge, effective, and repeatable solution with reasonable costs to prolong access survival avoiding additional surgery. The failure rate in the mid-term for dysfunctional vascular access may also be high after surgical reintervention.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

